Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients

Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients

Background: The biomarkers of immune checkpoint inhibitors (ICIs) efficacy and safety are still urgently needed. As cytokines are easily detected and monitored in circulation, they could be used as potential predictors of response and immune-related adverse events (irAEs) for ICIs therapy. Methods:...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Katarina Mirjačić Martinović, Ana Vuletić, Nevena Tišma Miletić, Irina Besu Žižak, Jelena Milovanović, Suzana Matković, Vladimir Jurišić
Định dạng:	Bài viết
Ngôn ngữ:	English
Được phát hành:	Elsevier 2023-12-01
Loạt:	Translational Oncology
Những chủ đề:	Metastatic melanoma patients BRAF wild type Pembrolizumab Cytokines Monitoring Outcome predictors
Truy cập trực tuyến:	http://www.sciencedirect.com/science/article/pii/S1936523323001857

Những quyển sách tương tự

Complete response in a patient with BRAF-mutant metastatic melanoma achieved with the multidisciplinary approach: a case report
Bằng: Hana Garaj, et al.
Được phát hành: (2024-01-01)

Factors influencing the prognosis in Braf wild-type metastatic malignant melanoma and the role of novel inflammation indices
Bằng: Senar Ebinç, et al.
Được phát hành: (2023-09-01)

A Case of Severe Diabetic Ketoacidosis Associated with Pembrolizumab Therapy in a Patient with Metastatic Melanoma
Bằng: Wu L, et al.
Được phát hành: (2021-02-01)

Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients
Bằng: Katarina Mirjačić Martinović, et al.
Được phát hành: (2023-04-01)

Combination Atezolizumab, Cobimetinib, and Vemurafenib as a Treatment Option in BRAF V600 Mutation–Positive Melanoma: Patient Selection and Perspectives
Bằng: Dugan MM, et al.
Được phát hành: (2024-07-01)

Clinical significance of <it>BRAF </it>mutations in metastatic melanoma
Bằng: Polsky David, et al.
Được phát hành: (2004-12-01)

A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report
Bằng: Francesca Consoli, et al.
Được phát hành: (2020-07-01)

Case report: Exceptional disease progression in a 70-year-old patient: generalized melanosis and melanuria in the course of metastatic melanoma - a case study
Bằng: Jacek Calik, et al.
Được phát hành: (2024-01-01)

Case report: Concurrent intrathecal and intravenous pembrolizumab for metastatic melanoma with leptomeningeal disease
Bằng: Xiang Dan, et al.
Được phát hành: (2024-04-01)

PEMBROLIZUMAB IN THE TREATMENT OF METASTATIC MELANOMA
Bằng: I. V. SAMOILENKO, et al.
Được phát hành: (2017-06-01)

Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive <i>BRAF</i> Mutant Advanced Melanoma
Bằng: Ernesto Rossi, et al.
Được phát hành: (2023-01-01)

A phase I, single‐center, open‐label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [14C] encorafenib in healthy male subjects
Bằng: Lance Wollenberg, et al.
Được phát hành: (2023-10-01)

Potential utilization of neopterin measurements in the assessment of pyrexia in metastatic melanoma treated with combined targeted therapy: a case report
Bằng: Bartoušková Marie, et al.
Được phát hành: (2020-08-01)

Real‐world survival of patients with advanced BRAF V600 mutated melanoma treated with front‐line BRAF/MEK inhibitors, anti‐PD‐1 antibodies, or nivolumab/ipilimumab
Bằng: Justin C. Moser, et al.
Được phát hành: (2019-12-01)

Systemic therapy of skin metastatic melanoma with BRAF gene mutation
Bằng: Yu. S. Shakh-Paronyants, et al.
Được phát hành: (2023-03-01)

A Dramatic Response to Second-Line Nivolumab and Ipilimumab in BRAF-V600-Mutated Metastatic Melanoma
Bằng: Dahlia Fedele, et al.
Được phát hành: (2024-01-01)

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
Bằng: Saba S. Shaikh, et al.
Được phát hành: (2022-11-01)

Melanoma: BRAFi Rechallenge
Bằng: Christoforos S. Kosmidis, et al.
Được phát hành: (2023-05-01)

Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals
Bằng: Milena Cavic, et al.
Được phát hành: (2023-04-01)

MEK inhibitors for the treatment of NRAS mutant melanoma
Bằng: Sarkisian S, et al.
Được phát hành: (2018-08-01)

The Human Melanoma Proteome Atlas—Complementing the melanoma transcriptome
Bằng: Lazaro Hiram Betancourt, et al.
Được phát hành: (2021-07-01)

Current State of Target Treatment in BRAF Mutated Melanoma
Bằng: Enrica Teresa Tanda, et al.
Được phát hành: (2020-07-01)

Fertility Outcomes and Sperm-DNA Parameters in Metastatic Melanoma Survivors Receiving Vemurafenib or Dabrafenib Therapy: Case Report
Bằng: Marco Ghezzi, et al.
Được phát hành: (2020-03-01)

Limbic encephalitis in metastatic malignant melanoma patient induced by PD-1 checkpoint inhibitor pembrolizumab
Bằng: Rozala Arko, et al.
Được phát hành: (2022-07-01)

Novel 5,6-dichlorobenzimidazole derivatives as dual BRAFWT and BRAFV600E inhibitors: design, synthesis, anti-cancer activity and molecular dynamics simulations
Bằng: Ahmed Temirak, et al.
Được phát hành: (2025-02-01)

p53 Promotes Cytokine Expression in Melanoma to Regulate Drug Resistance and Migration
Bằng: Pinakin Pandya, et al.
Được phát hành: (2022-01-01)

Update on the treatment of BRAFmut metastatic melanoma and future perspectives
Bằng: Peter Mohr, et al.
Được phát hành: (2025-03-01)

BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma
Bằng: Karam Khaddour, et al.
Được phát hành: (2021-06-01)

Triple combination of vemurafenib, cobimetinib, and atezolizumab in real clinical practice in the Russian Federation: results of the A1 cohort of the ISABELLA study
Bằng: Igor V. Samoylenko, et al.
Được phát hành: (2024-10-01)

Improved overall survival in dual compared to single immune checkpoint inhibitors in BRAF V600-negative advanced melanoma
Bằng: Adi Kartolo, et al.
Được phát hành: (2022-03-01)

BRAF L485–P490 deletion mutant metastatic melanoma sensitive to BRAF and MEK inhibition: A case report and literature review
Bằng: Simeng Zhang, et al.
Được phát hành: (2023-01-01)

Rapidly progressing metastatic malignant melanoma mimicking primary pleural tumor: A case report
Bằng: Clara So, et al.
Được phát hành: (2022-05-01)

Braf protein mutation and its significancy within patients with melanoma
Bằng: Julia Kuchnicka, et al.
Được phát hành: (2022-08-01)

Treatment of Advanced Melanoma: Past, Present and Future
Bằng: Taku Fujimura, et al.
Được phát hành: (2020-09-01)

Comparison of Two Rapid Assays for the Detection of <i>BRAF</i> V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes
Bằng: Elodie Long-Mira, et al.
Được phát hành: (2022-03-01)

Safety and rapid response of dabrafenib and trametinib therapy during hyperbilirubinemia in metastatic melanoma
Bằng: Walid Shalata, et al.
Được phát hành: (2023-02-01)

Case Report: Dynamic overlap of melanoma, sarcoidosis, and targeted therapy for BRAF-mutant melanoma
Bằng: Nakul Dar, et al.
Được phát hành: (2023-08-01)

Association between braf gene mutation status and clinical-morphological features of cutaneous melanoma
Bằng: O. I. Kit, et al.
Được phát hành: (2016-06-01)

PROMISES FOR TREATING COLON CANCER PATIENTS WITH BRAF GENE MUTATION
Bằng: M. Yu. Fedyanin, et al.
Được phát hành: (2015-02-01)

Anal Canal Melanoma: Challenging the Odds
Bằng: Sara Magno, et al.
Được phát hành: (2024-02-01)